Release Date: 23/01/14 18:11 Summary: Activity Report & Appendix 4C Price Sensitive: Yes Download Document 151.86KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%